Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0320
+0.0010 (3.23%)
Dec 23, 2024, 1:22 PM EST
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $10.96 million as of December 26, 2024. Its market cap has decreased by -34.50% in one year.
Market Cap
10.96M
Enterprise Value
23.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 10.96M, an increase of 19.83%. That is a compound annual growth rate of 3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 10.96M | -28.25% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | 19.26M | 34.48% |
| Dec 31, 2019 | 14.32M | 56.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 18.23B |
| Telix Pharmaceuticals Limited | 5.14B |
| Elekta AB (publ) | 2.09B |
| Ryman Healthcare Limited | 1.67B |
| Verano Holdings Corp. | 471.76M |
| Vireo Growth Inc. | 126.59M |
| Medexus Pharmaceuticals Inc. | 48.37M |